Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23

ACS Chemical Neuroscience

Volumn 1, Issue 11, 2010, Pages 747-756

  Murakami, Kazuma ^a,b   Horikoshi Sakuraba, Yuko ^c   Murata, Nakaba ^b,d   Noda, Yoshihiro ^b   Masuda, Yuichi ^a   Kinoshita, Noriaki ^c   Hatsuta, Hiroyuki ^b   Murayama, Shigeo ^b   Shirasawa, Takuji ^e   Shimizu, Takahiko ^b,d   Irie, Kazuhiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c Immuno Biological Laboratories Co Ltd   (Japan)

^d TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^e JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; MONOCLONAL ANTIBODY; MUTANT PROTEIN; OLIGOMER; PROLINE;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CLONING; MOUSE; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; SURFACE PLASMON RESONANCE; WESTERN BLOTTING;

ALZHEIMER'S DISEASE; AMYLOID; HUMAN BRAIN; NEUROTOXICITY; TRANSGENIC MICE; TURN;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; AMINO ACIDS; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BRAIN CHEMISTRY; CELL SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PC12 CELLS; PROTEIN CONFORMATION; RATS; SURFACE PLASMON RESONANCE;

EID: 78649474332     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn100072e     Document Type: Article

References (42)

1. Glenner, G. G. and Wong, C. W. (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem. Biophys. Res. Commun. 120, 885-890
2. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. U. S. A. 82, 4245-4249
3. Haass, C. and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid β-peptide Nat. Rev. Mol. Cell. Biol. 8, 101-112
4. Behl, C., Davis, J. B., Lesley, R., and Schubert, D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77, 817-827
5. Barnham, K. J., Masters, C. L., and Bush, A. I. (2004) Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discovery 3, 205-214
6. Varadarajan, S., Yatin, S., Aksenova, M., and Butterfield, D. A. (2000) Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity J. Struct. Biol. 130, 184-208
7. Murakami, K., Irie, K., Ohigashi, H., Hara, H., Nagao, M., Shimizu, T., and Shirasawa, T. (2005) Formation and stabilization model of the 42-mer Abeta radical: implications for the long-lasting oxidative stress in Alzheimer's disease J. Am. Chem. Soc. 127, 15168-15174
8. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416, 535-539
9. Roychaudhuri, R., Yang, M., Hoshi, M. M., and Teplow, D. B. (2009) Amyloid β-protein assembly and Alzheimer disease J. Biol. Chem. 284, 4749-4753
10. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., and Seubert, P. (1999) Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400, 173-177
11. Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., Connor, K., Hatcher, J., Hope, C., Gordon, M., and Arendash, G. W. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408, 982-985
12. Orgogozo, J. M., Gilman, S., Dartigues, J. F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., Michel, B. F., Boada, M., Frank, A., and Hock, C. (2003) Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization Neurology 61, 46-54
13. Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., Zotova, E., and Nicoll, J. A. (2008) Long-term effects of Aβ42 immunisation in Alzheimer's disease: Follow-up of a randomised, placebo-controlled phase I trial Lancet 372, 216-223
14. Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., and Moir, R. D. (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide PLoS One 5, e9505
15. Masuda, Y., Uemura, S., Ohashi, R., Nakanishi, A., Takegoshi, K., Shimizu, T., Shirasawa, T., and Irie, K. (2009) Identification of physiological and toxic conformations in Aβ42 aggregates ChemBioChem 10, 287-295
16. Chou, P. Y. and Fasman, G. D. (1977) Beta-turns in proteins J. Mol. Biol. 115, 135-175
17. Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T., and Shirasawa, T. (2003) Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: Implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease J. Biol. Chem. 278, 46179-46187
18. Morimoto, A., Irie, K., Murakami, K., Masuda, Y., Ohigashi, H., Nagao, M., Fukuda, H., Shimizu, T., and Shirasawa, T. (2004) Analysis of the secondary structure of β-amyloid (Aβ42) fibrils by systematic proline replacement J. Biol. Chem. 279, 52781-52788
19. Williams, A. D., Portelius, E., Kheterpal, I., Guo, J. T., Cook, K. D., Xu, Y., and Wetzel, R. (2004) Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis J. Mol. Biol. 335, 833-842
20. Wisniewski, H. M., Wen, G. Y., and Kim, K. S. (1989) Comparison of four staining methods on the detection of neuritic plaques Acta Neuropathol. 78, 22-27
21. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300, 486-489
22. Meli, G., Visintin, M., Cannistraci, I., and Cattaneo, A. (2009) Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers J. Mol. Biol. 387, 584-606
23. Noguchi, A., Matsumura, S., Dezawa, M., Tada, M., Yanazawa, M., Ito, A., Akioka, M., Kikuchi, S., Sato, M., Ideno, S., Noda, M., Fukunari, A., Muramatsu, S., Itokazu, Y., Sato, K., Takahashi, H., Teplow, D. B., Nabeshima, Y., Kakita, A., Imahori, K., and Hoshi, M. (2009) Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains J. Biol. Chem. 284, 32895-32905
24. LaFerla, F. M., Troncoso, J. C., Strickland, D. K., Kawas, C. H., and Jay, G. (1997) Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization J. Clin. Invest. 100, 310-320
25. Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., Greengard, P., and Relkin, N. R. (2000) Intraneuronal Abeta42 accumulation in human brain Am. J. Pathol. 156, 15-20
26. LaFerla, F. M., Green, K. N., and Oddo, S. (2007) Intracellular amyloid-beta in Alzheimer's disease Nat. Rev. Neurosci. 8, 499-509
27. Gomez-Ramos, P. and Asuncion Moran, M. (2007) Ultrastructural localization of intraneuronal Abeta-peptide in Alzheimer disease brains J. Alzheimers Dis. 11, 53-59
28. Ohyagi, Y. (2008) Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease Curr. Alzheimer Res. 5, 555-561
29. Fernandez-Vizarra, P., Fernandez, A. P., Castro-Blanco, S., Serrano, J., Bentura, M. L., Martinez-Murillo, R., Martinez, A., and Rodrigo, J. (2004) Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease Histol. Histopathol. 19, 823-844 (Pubitemid 38855065)
30. Ohyagi, Y., Tsuruta, Y., Motomura, K., Miyoshi, K., Kikuchi, H., Iwaki, T., Taniwaki, T., and Kira, J. (2007) Intraneuronal amyloid beta42 enhanced by heating but counteracted by formic acid J. Neurosci. Methods 159, 134-138
31. Christensen, D. Z., Bayer, T. A., and Wirths, O. (2009) Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Abeta peptides in mouse models of Alzheimer's disease Brain Res. 1301, 116-125
32. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., and LaFerla, F. M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction Neuron 39, 409-421
33. Horikoshi, Y., Sakaguchi, G., Becker, A. G., Gray, A. J., Duff, K., Aisen, P. S., Yamaguchi, H., Maeda, M., Kinoshita, N., and Matsuoka, Y. (2004) Development of Abeta terminal end-specific antibodies and sensitive ELISA for Abeta variant Biochem. Biophys. Res. Commun. 319, 733-737
34. Selkoe, D. J. (1994) Normal and abnormal biology of the beta-amyloid precursor protein Annu. Rev. Neurosci. 17, 489-517
35. Saido, T. C., Iwatsubo, T., Mann, D. M., Shimada, H., Ihara, Y., and Kawashima, S. (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques Neuron 14, 457-466
36. Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T., and Shirasawa, T. (2002) Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23 Biochem. Biophys. Res. Commun. 294, 5-10
37. Irie, K., Oie, K., Nakahara, A., Yanai, Y., Ohigashi, H., Wender, P. A., Fukuda, H., Konishi, H., and Kikkawa, U. (1998) Molecular basis for protein kinase C isozyme-selective binding: the synthesis, folding, and phorbol ester binding of the cysteine-rich domains of all protein kinase C isozymes J. Am. Chem. Soc. 120, 9159-9167
38. Shearman, M. S., Ragan, C. I., and Iversen, L. L. (1994) Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death Proc. Natl. Acad. Sci. U. S. A. 91, 1470-1474
39. Murayama, S. and Saito, Y. (2004) Neuropathological diagnostic criteria for Alzheimer's disease Neuropathology 24, 254-260
40. Braak, H. and Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82, 239-259
41. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274, 99-102
42. Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., and McConlogue, L. (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J. Neurosci. 20, 4050-4058